These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 32386189)
1. ACE Ins/Del genetic polymorphism and epidemiological findings in COVID-19. Delanghe JR; Speeckaert MM; De Buyzere ML Clin Chem Lab Med; 2020 Jun; 58(7):1129-1130. PubMed ID: 32386189 [No Abstract] [Full Text] [Related]
2. No significant correlation between ACE Ins/Del genetic polymorphism and COVID-19 infection. Saadat M Clin Chem Lab Med; 2020 Jun; 58(7):1127-1128. PubMed ID: 32386188 [No Abstract] [Full Text] [Related]
3. Sex-mediated effects of ACE2 and TMPRSS2 on the incidence and severity of COVID-19; The need for genetic implementation. Alshahawey M; Raslan M; Sabri N Curr Res Transl Med; 2020 Nov; 68(4):149-150. PubMed ID: 32917573 [No Abstract] [Full Text] [Related]
4. The host's angiotensin-converting enzyme polymorphism may explain epidemiological findings in COVID-19 infections. Delanghe JR; Speeckaert MM; De Buyzere ML Clin Chim Acta; 2020 Jun; 505():192-193. PubMed ID: 32220422 [No Abstract] [Full Text] [Related]
5. Binding of SARS-CoV-2 and angiotensin-converting enzyme 2: clinical implications. Murray E; Tomaszewski M; Guzik TJ Cardiovasc Res; 2020 Jun; 116(7):e87-e89. PubMed ID: 32301968 [No Abstract] [Full Text] [Related]
11. Angiotensin Converting Enzyme-2 (ACE2) Receptors, asthma and severe COVID-19 infection risk. Öztürk AB; Çağlayan B Eur Ann Allergy Clin Immunol; 2020 Nov; 52(6):282-285. PubMed ID: 32914945 [No Abstract] [Full Text] [Related]
12. Response to recent commentaries regarding the involvement of angiotensin-converting enzyme 2 (ACE2) and renin-angiotensin system blockers in SARS-CoV-2 infections. Speth RC Drug Dev Res; 2020 Sep; 81(6):643-646. PubMed ID: 32304146 [No Abstract] [Full Text] [Related]
13. Do genetic polymorphisms in angiotensin converting enzyme 2 (ACE2) gene play a role in coronavirus disease 2019 (COVID-19)? Lippi G; Lavie CJ; Henry BM; Sanchis-Gomar F Clin Chem Lab Med; 2020 Aug; 58(9):1415-1422. PubMed ID: 32598305 [TBL] [Abstract][Full Text] [Related]
14. [ACE2 and coronavirus - a question of balance and dynamics?]. Lundström A; Sandén P Lakartidningen; 2020 Apr; 117():. PubMed ID: 32314329 [TBL] [Abstract][Full Text] [Related]
15. Can estrogens protect against COVID-19? The COVID-19 puzzling and gender medicine. Bonaccorsi G; Gambacciani M; Gemmati D Minerva Ginecol; 2020 Jun; 72(3):178-179. PubMed ID: 33000616 [No Abstract] [Full Text] [Related]
16. ACE2 receptor expression in testes: implications in coronavirus disease 2019 pathogenesis†. Verma S; Saksena S; Sadri-Ardekani H Biol Reprod; 2020 Aug; 103(3):449-451. PubMed ID: 32427288 [TBL] [Abstract][Full Text] [Related]
17. Angiotensin-converting enzyme 2, sex differences, and COVID-19: The missing link. Van den Eynde J; McCutcheon KRG Int J Cardiol; 2021 Jan; 322():293. PubMed ID: 32920066 [No Abstract] [Full Text] [Related]
18. Covid-19 and the angiotensin-converting enzyme (ACE2): Areas for research. Omar MB Heart Lung; 2020; 49(4):351. PubMed ID: 32327200 [No Abstract] [Full Text] [Related]
19. [Genetic and epigenetic variability, and the Covid-19 pandemic]. Rivera-Silva G Salud Publica Mex; 2020; 62(5):462-463. PubMed ID: 32668509 [No Abstract] [Full Text] [Related]
20. [Angiotensin-converting enzyme 2 and coronavirus: research update on pathogenesis of the infection induced by this indissoluble bond]. Hou P; Xu Q; Na J; Zhang BL; Wu H; Li P; Zhao XX Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jul; 48(7):539-545. PubMed ID: 32159318 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]